Skip to content
WeighLab

NextMeds vs Rewinding RX

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

NextMeds

Provider comparison

Shoppers who will call out and verify the exact price at checkout, given the site shows several different promo numbers at once.

Semaglutide / month
$49/moDated enrollment offer, all doses, compounded; ends October 31
Tirzepatide / month
$119/moDated enrollment offer, all doses, compounded; ends October 31
Index 87/100 · Grade B+Checked October 2026

Rewinding RX

Provider comparison

Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.

Semaglutide / month
$139/moAll doses, standard compounded injection
Tirzepatide / month
$189/moAll doses, standard compounded injection
Index 85/100 · Grade BChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

NextMeds has the higher Cost-Efficiency Index: 87/100 versus 85/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

NextMeds

Rewinding RX

Semaglutide / month
NextMeds: $49/moDated enrollment offer, all doses, compounded; ends October 31
Rewinding RX: $139/moAll doses, standard compounded injection
Tirzepatide / month
NextMeds: $119/moDated enrollment offer, all doses, compounded; ends October 31
Rewinding RX: $189/moAll doses, standard compounded injection
Semaglutide / year (modeled)
NextMeds: $588
Rewinding RX: $1,668
Tirzepatide / year (modeled)
NextMeds: $1,428
Rewinding RX: $2,268
State availability
NextMeds: All 50 states
Rewinding RX: All 50 states
Oral / sublingual option listed
NextMeds: Not listed
Rewinding RX: Yes
Brand-name access listed
NextMeds: Yes
Rewinding RX: Not confirmed
Provider facts checked
NextMeds: October 2026
Rewinding RX: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

NextMeds

Shoppers who will call out and verify the exact price at checkout, given the site shows several different promo numbers at once.

Reasons to consider it

  • Publishes a dated drug-category enrollment offer
  • Names OpenLoop Healthcare Partners and four dispensing partners
  • Telehealth consultations, prescribed medication and shipping included

What to weigh up

  • The enrollment offer ends October 31 at midnight; confirm the timezone and ongoing charge
  • Brand-name products have no public price
  • Refunds are restricted to medical disqualification

Rewinding RX

Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.

Reasons to consider it

  • Publishes flat monthly prices for standard injection products
  • Consultation, medication, messaging and express shipping are included
  • Separate oral-drop and microdose options

What to weigh up

  • Microdose and standard-dose products have different prices
  • No dispensing pharmacy or medical director is named
  • Prescription medication is non-refundable; defective or incorrect products are replaced

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

NextMedsRewinding RX
Normalized Cost/Month
NextMeds:
97/100
Rewinding RX:
91/100
Price Transparency
NextMeds:
97/100
Rewinding RX:
94/100
Nationwide Access
NextMeds:
86/100
Rewinding RX:
86/100
Formulation Options
NextMeds:
79/100
Rewinding RX:
77/100
Clinical Oversight
NextMeds:
83/100
Rewinding RX:
89/100
Contract Flexibility
NextMeds:
67/100
Rewinding RX:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.